Effect of Clinical Characteristics on Neutropenia‐Related Inpatient Costs Among Newly Diagnosed Non‐Hodgkin's Lymphoma Cases During First‐Course Chemotherapy - Concepedia

Concepedia

Publication | Closed Access

Effect of Clinical Characteristics on Neutropenia‐Related Inpatient Costs Among Newly Diagnosed Non‐Hodgkin's Lymphoma Cases During First‐Course Chemotherapy

10

Citations

11

References

2005

Year

Elizabeth A. Chrischilles, Donald G. Klepser, John M. Brooks, Margaret D. Voelker, Shari Chen-Hardee, Shannon D. Scott, Brian K. Link, David J. Delgado

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

Abstract

When estimating expected payments for neutropenia-related hospitalization in patients with non-Hodgkin's lymphoma, payers need to be aware of the distribution of clinical characteristics in these patients.

References

	Year	Citations
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases Richard A. Deyo Journal of Clinical Epidemiology Primary CarePsychiatryHealth PolicyMedicineClinical Database	1992	10.4K
Potential for Cancer Related Health Services Research Using a Linked Medicare-Tumor Registry Database Arnold L. Potosky, Gerald F. Riley, James Lubitz, Medical Care Cancer ManagementEpidemiology Of CancerCancer RegistrationPublic HealthMedicare-tumor Registry Database	1993	707
Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis. Larry W. Kwak, Jerry Halpern, Richard A. Olshen, Journal of Clinical Oncology PrognosisPathologyDose IntensityPrognostic SignificancePharmacotherapy	1990	433
Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. Dennis O. Dixon, Barbara A. Neilan, Siân Jones, Journal of Clinical Oncology Cancer ManagementPathologyPharmacotherapyMetronomic ChemotherapyImmunotherapy	1986	362
Cost of care for cancer in a health maintenance organization. Bruce Fireman, C. P. Quesenberry, Carol P. Somkin, PubMed Health AdministrationCancer ManagementKaiser PermanenteDirect CostsOncology	1997	199
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol Éric Lepage, C Gisselbrecht, Corinne Haïoun, Annals of Oncology Lymphoid NeoplasiaPrognostic EvaluationMedicineMalignant Blood DisorderPrognosis	1993	171
The Impact of Age on Delivered Dose Intensity and Hospitalizations for Febrile Neutropenia in Patients with Intermediate-Grade Non-Hodgkin's Lymphoma Receiving Initial CHOP Chemotherapy: A Risk Factor Analysis Vicki A. Morrison, Vincent J. Picozzi, Brad Pohlman, Clinical Lymphoma Lymphoid NeoplasiaIntermediate-grade Non-hodgkinMedicineMalignant Blood DisorderClinical Epidemiology	2001	144
Impact of Age and Colony-Stimulating Factor Use on Hospital Length of Stay for Febrile Neutropenia in CHOP-Treated Non-Hodgkin's Lymphoma Elizabeth A. Chrischilles, David J. Delgado, Bradley S. Stolshek, Cancer Control	2002	77
Construct Validity of Medicare Chemotherapy Claims Elizabeth B. Lamont, Diane S. Lauderdale, Richard L. Schilsky, Medical Care	2002	50
Information Gained From Linking SEER Cancer Registry Data to State-Level Hospital Discharge Abstracts John M. Brooks, Elizabeth A. Chrischilles, Jane Ritho, Medical Care	2000	33

Page 1